IRCT2016080318745N10Completed未知
Assessment of insulin-like growth factor I and its signaling pathways in the serum and the tissue of gastric cancer patients
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 40 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criteria include: 40-70 years old patients with dyspepsia; the patients with written consent; the patients with no history of cancer or special disease.
- •Exclusion criteria include: the patients with diabetes type 1 or 2; the patients with obesity; the patients with smoking.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
Pioglitazone in the treatment of acromegalyMetabolic and Endocrine - Metabolic disordersAcromegalyACTRN12610000780055Auckland district health board20
Enrolling By Invitation
Not Applicable
Expression of insulin-like growth factors as a prognostic factor in solitary fibrous tumorsICD-10-CM Z85.110 Personal history of malignant carcinoid tumor of bronchus and lungDRKS00021109niversitätsklinikum Freiburg Klinik für Thoraxchirurgie100
Completed
Phase 1
Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in AdolescentsAnorexia NervosaNCT00516386Massachusetts General Hospital16
Terminated
Not Applicable
Constructing an Insulin-Like Growth Factor-based Prediction ModelIdiopathic Short StatureGrowth Hormone DeficiencySmall for Gestational AgeNCT00263445University of California, Los Angeles30
Completed
Not Applicable
Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrestJPRN-UMIN000018553Emergency and critical care center30